Search

How Can We Help You?

Video

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Lung Cancer Trials

Select Clinical Trial

Protocol Number: ALCHEMIST

Protocol Title: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial

Eligibility: Men or women, ages 18 or older, diagnosed with Stage IIIA, II or large IB non-small cell lung cancer (NSCLC). 

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: MS200647_0005

Protocol Title:  A multicenter, double blind, randomized, controlled study of M7824 with concurrent chemoradiation followed by M7824 versus concurrent chemoradiation plus placebo followed by Durvalumab

Eligibility: Men or women, ages 18 and older, diagnosed with non-small cell lung cancer, stage III locally advanced, unresectable disease.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: LUNGMAP

Protocol Title: Master Protocol to evaluate biomarker-driven therapies and immunotherapies in previously-treated non-small cell lung cancer (Lung-MAP Screening Study)

Eligibility: Men or women, ages 18 and older, diagnosed with non-small cell lung cancer, DISEASE MUST BE EITHER ADVANCED, stage IIIB or IV or recurrent.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: NRG-LU005

Protocol Title: LIMITED STAGE SMALL CELL LUNG CANCER (LS-SCLC): A PHASE II/III RANDOMIZED STUDY OF CHEMORADIATION VERSUS CHEMORADIATION PLUS ATEZOLIZUMAB

Eligibility: Men or women, ages 18 and older, diagnosed with limited stage small cell lung cancer.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: FDI 209

Protocol Title: A Prospective Longitudinal Collection of Peripheral Blood to Support the Validation of Biomarkers as an Aid in Monitoring Disease in Patients with all Stages of Lung Cancer

Eligibility: Men and women age 18 and older, diagnosed with Lung Cancer.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: SWOG 1914; NCT04214262

Protocol Title:  A Randomized Phase III Trial of Induction/ Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage Non-Small Cell Lung Cancer

Eligibility: Men and women age 18 and older, diagnosed with Early Stage Non-Small Cell Lung Cancer that are not candidates for surgical resection.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: SWOG 1929; NCT04334941

Protocol Title:  Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Eligibility: Men and women age 18 and older, diagnosed with Extensive Stage Small Cell lung cancer.

Contact Information: (910) 715-2200

Specialties
Clara McLean House
Make a Donation
News & Events